Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study

Jaroslav J. Marik, J J Marik, Marik JJ
Obstetrics and gynecology · 1998 · vol. 91(5, Part 1) , pp. 793 · doi:10.1097/00006250-199805000-00029 · PMID:9572232 · W2614428623
Other OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This study investigated the efficacy of leuprolide acetate depot combined with hormonal add-back therapy for managing endometriosis symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Estrogens, Conjugated (USP) Leuprolide Norethindrone Drug Therapy, Combination Drug Therapy, Combination Endometriosis Endometriosis Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Female Female Humans Humans Leuprolide Leuprolide Norethindrone Norethindrone Norethindrone Norethindrone Acetate

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

crossref
last seen: 2026-05-17T01:00:18.210877+00:00
europepmc
last seen: 2026-10-24T06:12:55.650802+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:35.617750+00:00
License: CC0 · commercial use OK